一个儿童和青少年专注于药物堕胎课程为多学科的学员.
Julia H Raney1,2, Chelsea A Garnett3,2, Amanda E Bryson4
1Assistant Professor of Pediatrics, Division of Adolescent and Young Adult Medicine, Stanford University.
MedEdPORTAL : the journal of teaching and learning resources
|November 17, 2025
概括
一个新的药物堕胎 (MAB) 课程显著提高了儿科学员对青少年和年轻成年人 (AYA) 的知识. 混合学习方法得到了很高的评价,尽管提供MAB护理的意图保持不变.
科学领域:
- 医学教育 医学教育
- 生殖健康 生殖健康
- 青少年医学 青少年医学
背景情况:
- 在罗诉韦德案之后,22个州限制了堕胎的机会,影响了青少年和年轻人 (AYA).
- 由于提供者培训缺口,AYA对堕胎护理的安全和及时访问有限.
- 没有专门的药物堕胎 (MAB) 课程为AYA.
研究的目的:
- 为儿科实习生开发和评估一个以AYA为重点的MAB课程.
- 为弥补专门培训的缺口,为AYA提供MAB.
- 增强医疗保健机构对MAB护理的提供者知识和信心.
主要方法:
- 一个混合学习课程,使用在线模块和一个工作坊,用Kern的六步设计.
- 前后调查评估了知识,价值观和意图,并对开放式答案进行了定性分析.
- 在2023-2024学年期间,评估涉及儿科住院生和护士从业学生的52名学习者.
主要成果:
- 课程后的知识分数显著增加 (60%至90%,p < .01).
- 学习者提供,转介或倡导MAB护理的意图没有显著变化 (4.3与4.3).
- 85%的学习者将课程评为优秀或优秀;基于案例的学习和角色扮演受到高度重视.
结论:
- 开发的课程有效地提高了学员在为AYA提供MAB方面的知识和信心.
- 该课程帮助学员预测MAB提供中具有挑战性的案例.
- 一般化可能受到当地政治气候,法律限制和机构支持的影响.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
188
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
188
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
219
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
219
Drug Dosing: Infants and Children
226
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
226
Pharmacokinetics in Pediatric Patients: Drug Metabolism
165
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
Dosage Regimens: Designs and Approaches
227
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
227


